{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:14:58Z","timestamp":1786324498666,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.ahj.2005.09.009","type":"journal-article","created":{"date-parts":[[2006,3,29]],"date-time":"2006-03-29T07:13:09Z","timestamp":1143616389000},"page":"863.e1-863.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned"],"prefix":"10.1016","volume":"151","author":[{"given":"Kunadian","family":"Vijayalakshmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria J.","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alun A.","family":"Harcombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Linker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"de Belder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2005.09.009_bib1","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","article-title":"Epidemiologic features of chronic atrial fibrillation: the Framingham Study","volume":"306","author":"Kannel","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.09.009_bib2","doi-asserted-by":"crossref","first-page":"23C","DOI":"10.1016\/S0002-9149(98)00183-0","article-title":"Drug treatment of atrial fibrillation in the managed care era","volume":"81","author":"Waldo","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.09.009_bib3","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention; the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.09.009_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.09.009_bib5","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","article-title":"Atrial fibrillation: a major contributor to stroke in the elderly","volume":"147","author":"Wolf","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.09.009_bib6","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.09.009_bib7","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.09.009_bib8","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJM199205073261906","article-title":"Management of atrial fibrillation","volume":"326","author":"Pritchett","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.09.009_bib9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrence of atrial fibrillation","volume":"342","author":"Roy","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.09.009_bib10","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1161\/01.CIR.82.6.1932","article-title":"Sotalol versus quinidine for the maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation","volume":"82","author":"Juul-Moller","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.09.009_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0002-9149(91)90707-R","article-title":"Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter","volume":"68","author":"Van Gelder","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.09.009_bib12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0002-9149(89)90049-0","article-title":"Usefulness of propafenone for recurrent atrial fibrillation","volume":"63","author":"Connolly","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.09.009_bib13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7326\/0003-4819-114-7-539","article-title":"Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias: a randomised, placebo-controlled, crossover trial in patients tolerating oral therapy","volume":"114","author":"Pritchett","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2005.09.009_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0002-9149(93)90511-A","article-title":"Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation","volume":"71","author":"Reimond","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.09.009_bib15","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/clc.4960221106","article-title":"The use of atropine for facilitation of direct current cardioversion from atrial fibrillation\u2014results of a pilot study","volume":"22","author":"Sutton","year":"1999","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ahj.2005.09.009_bib16","series-title":"Practical statistics for medical research","author":"Altman","year":"1991"},{"key":"10.1016\/j.ahj.2005.09.009_bib17","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.09.009_bib18","first-page":"431","article-title":"Amiodarone versus quinidine in the prophylaxis of atrial fibrillation","volume":"36","author":"Vitolo","year":"1981","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.ahj.2005.09.009_bib19","doi-asserted-by":"crossref","first-page":"75F","DOI":"10.1016\/0002-9149(93)90967-H","article-title":"Low dose amiodarone for atrial fibrillation","volume":"72","author":"Middlekauff","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.09.009_bib20","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/archinte.1995.00430170081010","article-title":"Treatment of resistant atrial fibrillation; a meta-analysis comparing amiodarone and flecainide","volume":"155","author":"Zarembski","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.09.009_bib21","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(97)05281-1","article-title":"Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 in randomised trials","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.09.009_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0002-8703(91)90969-O","article-title":"Side effects of amiodarone","volume":"121","author":"Wilson","year":"1991","journal-title":"Am Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305008641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305008641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:28:10Z","timestamp":1757568490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870305008641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0002870305008641"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2005.09.009","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2005.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}